Predictive Oncology Inc. (POAI)
USD 0.73
(-1.35%)
USD 0.73
(-1.35%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 15.22 Million USD | -11.76% |
| 2022 | 16.26 Million USD | 12.93% |
| 2021 | 14.4 Million USD | 8.4% |
| 2020 | 13.28 Million USD | -9.32% |
| 2019 | 14.65 Million USD | 65.45% |
| 2018 | 8.85 Million USD | 7.32% |
| 2017 | 8.25 Million USD | 21.36% |
| 2016 | 6.8 Million USD | 43.18% |
| 2015 | 4.75 Million USD | -32.47% |
| 2014 | 7.03 Million USD | -23.6% |
| 2013 | 9.2 Million USD | 27.51% |
| 2012 | 7.21 Million USD | 74.14% |
| 2011 | 4.14 Million USD | 243.84% |
| 2010 | 1.2 Million USD | -50.83% |
| 2009 | 2.45 Million USD | 46.56% |
| 2008 | 1.67 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.15 Million USD | -26.83% |
| 2024 Q1 | 4.3 Million USD | 25.38% |
| 2023 Q1 | 3.58 Million USD | -22.72% |
| 2023 Q4 | 3.43 Million USD | -8.71% |
| 2023 Q3 | 3.76 Million USD | -8.83% |
| 2023 Q2 | 4.12 Million USD | 15.12% |
| 2023 FY | 14.35 Million USD | -11.76% |
| 2022 Q3 | 4.47 Million USD | 26.8% |
| 2022 Q2 | 3.53 Million USD | -2.41% |
| 2022 FY | 16.26 Million USD | 12.93% |
| 2022 Q1 | 3.61 Million USD | -23.91% |
| 2022 Q4 | 4.63 Million USD | 3.58% |
| 2021 Q3 | 2.88 Million USD | 2.77% |
| 2021 FY | 14.4 Million USD | 8.4% |
| 2021 Q4 | 4.75 Million USD | 64.96% |
| 2021 Q2 | 2.8 Million USD | -29.16% |
| 2021 Q1 | 3.96 Million USD | 38.27% |
| 2020 Q2 | 3.86 Million USD | 6.16% |
| 2020 Q3 | 2.91 Million USD | -24.55% |
| 2020 FY | 13.28 Million USD | -9.32% |
| 2020 Q1 | 3.64 Million USD | 17.11% |
| 2020 Q4 | 2.86 Million USD | -1.81% |
| 2019 FY | 14.65 Million USD | 65.45% |
| 2019 Q1 | 2.51 Million USD | -16.94% |
| 2019 Q2 | 5.26 Million USD | 109.1% |
| 2019 Q3 | 3.75 Million USD | -28.62% |
| 2019 Q4 | 3.1 Million USD | -17.29% |
| 2018 FY | 8.85 Million USD | 7.32% |
| 2018 Q2 | 1.66 Million USD | -19.07% |
| 2018 Q1 | 2.05 Million USD | -32.18% |
| 2018 Q4 | 3.03 Million USD | 43.86% |
| 2018 Q3 | 2.1 Million USD | 26.8% |
| 2017 Q4 | 3.02 Million USD | 171.44% |
| 2017 FY | 8.25 Million USD | 21.36% |
| 2017 Q1 | 1.48 Million USD | 76.23% |
| 2017 Q3 | 1.11 Million USD | -57.54% |
| 2017 Q2 | 2.62 Million USD | 77.6% |
| 2016 Q4 | 839.84 Thousand USD | -27.83% |
| 2016 FY | 6.8 Million USD | 43.18% |
| 2016 Q3 | 1.16 Million USD | -55.41% |
| 2016 Q2 | 2.6 Million USD | 19.32% |
| 2016 Q1 | 2.18 Million USD | -6.74% |
| 2015 Q3 | 1.13 Million USD | -1.39% |
| 2015 Q2 | 1.14 Million USD | 799.41% |
| 2015 Q1 | 127.47 Thousand USD | -94.2% |
| 2015 FY | 4.75 Million USD | -32.47% |
| 2015 Q4 | 2.34 Million USD | 107.44% |
| 2014 FY | 7.03 Million USD | -23.6% |
| 2014 Q4 | 2.19 Million USD | 76.37% |
| 2014 Q1 | 1.64 Million USD | -24.28% |
| 2014 Q2 | 1.94 Million USD | 17.68% |
| 2014 Q3 | 1.24 Million USD | -35.82% |
| 2013 Q3 | 3.71 Million USD | 209.1% |
| 2013 Q1 | 2.11 Million USD | 32.67% |
| 2013 Q4 | 2.17 Million USD | -41.35% |
| 2013 Q2 | 1.2 Million USD | -43.09% |
| 2013 FY | 9.2 Million USD | 27.51% |
| 2012 Q3 | 2.83 Million USD | 33.05% |
| 2012 Q4 | 1.59 Million USD | -43.81% |
| 2012 FY | 7.21 Million USD | 74.14% |
| 2012 Q2 | 2.12 Million USD | 218.97% |
| 2012 Q1 | 667.35 Thousand USD | -74.13% |
| 2011 Q1 | 424.26 Thousand USD | 163.49% |
| 2011 Q3 | 625.19 Thousand USD | 20.94% |
| 2011 Q4 | 2.57 Million USD | 312.6% |
| 2011 FY | 4.14 Million USD | 243.84% |
| 2011 Q2 | 516.93 Thousand USD | 21.84% |
| 2010 FY | 1.2 Million USD | -50.83% |
| 2010 Q3 | 473.11 Thousand USD | -14.14% |
| 2010 Q4 | -668.27 Thousand USD | -241.25% |
| 2010 Q2 | 551 Thousand USD | -35.17% |
| 2010 Q1 | 849.92 Thousand USD | 134.05% |
| 2009 Q4 | 363.14 Thousand USD | -55.4% |
| 2009 FY | 2.45 Million USD | 46.56% |
| 2009 Q3 | 814.27 Thousand USD | 4.28% |
| 2009 Q2 | 780.87 Thousand USD | 58.04% |
| 2009 Q1 | 494.09 Thousand USD | -32.23% |
| 2008 FY | 1.67 Million USD | 0.0% |
| 2008 Q3 | 443.4 Thousand USD | 0.0% |
| 2008 Q4 | 729.06 Thousand USD | 64.43% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 104.27 Million USD | 85.394% |
| AngioDynamics, Inc. | 252.41 Million USD | 93.966% |
| AtriCure, Inc. | 327.05 Million USD | 95.343% |
| Avinger, Inc. | 18.63 Million USD | 18.288% |
| Azenta, Inc. | 336.26 Million USD | 95.471% |
| BioLife Solutions, Inc. | 117.57 Million USD | 87.047% |
| The Cooper Companies, Inc. | 1.82 Billion USD | 99.165% |
| Daxor Corporation | 1.28 Million USD | -1089.329% |
| Ekso Bionics Holdings, Inc. | 24.19 Million USD | 37.045% |
| Femasys Inc. | 15.2 Million USD | -0.192% |
| GlucoTrack, Inc. | 7.1 Million USD | -114.38% |
| Harvard Bioscience, Inc. | 58.58 Million USD | 74.003% |
| Hologic, Inc. | 1.34 Billion USD | 98.868% |
| ICU Medical, Inc. | 717.04 Million USD | 97.876% |
| Intuitive Surgical, Inc. | 2.96 Billion USD | 99.486% |
| KORU Medical Systems, Inc. | 26.1 Million USD | 41.667% |
| LeMaitre Vascular, Inc. | 90.33 Million USD | 83.141% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12862.639% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 12862.639% |
| Masimo Corporation | 867 Million USD | 98.243% |
| Microbot Medical Inc. | 9.85 Million USD | -54.536% |
| Meihua International Medical Technologies Co., Ltd. | 18.42 Million USD | 17.321% |
| Merit Medical Systems, Inc. | 459.92 Million USD | 96.689% |
| Nephros, Inc. | 9.78 Million USD | -55.658% |
| NovoCure Limited | 613.92 Million USD | 97.519% |
| NEXGEL, Inc. | 4.09 Million USD | -271.815% |
| NEXGEL, Inc. | 4.09 Million USD | -271.815% |
| Singular Genomics Systems, Inc. | 102.24 Million USD | 85.105% |
| OraSure Technologies, Inc. | 125.34 Million USD | 87.85% |
| Pro-Dex, Inc. | 7.37 Million USD | -106.418% |
| Pulse Biosciences, Inc. | 43.57 Million USD | 65.049% |
| Precision Optics Corporation, Inc. | 8.52 Million USD | -78.706% |
| QuidelOrtho Corporation | 1.35 Billion USD | 98.876% |
| Repligen Corporation | 261.12 Million USD | 94.168% |
| Sanara MedTech Inc. | 61.12 Million USD | 75.086% |
| STAAR Surgical Company | 224.55 Million USD | 93.218% |
| Sharps Technology, Inc. | 10.12 Million USD | -50.391% |
| Utah Medical Products, Inc. | 13.26 Million USD | -14.845% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.151% |
| Jin Medical International Ltd. | 3.91 Million USD | -288.749% |